Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | HTT | P42858 | 2/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.66 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.66 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.66 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.66 |
| ▸ | TUBB | P07437 | 1/20 | 0.66 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.66 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.66 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.66 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.66 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.66 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.66 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.66 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.66 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylisoeugenol SCHEMBL29518298 | 1.00 | TYR (0.69) | TYRMAPTSMN1; SMN2LMNAHTT | |
| Methylisoeugenol SCHEMBL29364555 | 1.00 | TYR (0.69) | TYRMAPTSMN1; SMN2LMNAHTT | |
| Methylisoeugenol SCHEMBL30203196 | 1.00 | TYR (0.69) | TYRMAPTSMN1; SMN2LMNAHTT | |
| Methylisoeugenol SCHEMBL1760676 | 1.00 | TYR (0.69) | TYRMAPTSMN1; SMN2LMNAHTT | |
| Methylisoeugenol SCHEMBL112937 | 1.00 | TYR (0.69) | TYRMAPTSMN1; SMN2LMNAHTT | |
| Methylisoeugenol SCHEMBL28544349 | 0.98 | TYR (0.67) | TYRMAPTSMN1; SMN2LMNAHTT | |
| Methylisoeugenol SCHEMBL28577260 | 0.98 | TYR (0.67) | TYRMAPTSMN1; SMN2LMNAHTT | |
| SCHEMBL27943686 | 0.92 | TYR (0.65) | TYRMAPTSMN1; SMN2LMNAHTT | |
| Methylisoeugenol SCHEMBL432122 | 0.89 | TYR (0.90) | TYRMAPTLMNAHTTNPSR1 | |
| Methylisoeugenol SCHEMBL29136251 | 0.89 | POLB (0.70) | TYRMAPTSMN1; SMN2LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 497 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| EP-4581114-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Novozymes A/S (DK) | 2025-07-09 | — | — | EP | claimed |
| US-20250134790-A1 | ANTIMICROBIAL COMPOSITIONS | FIRMENICH SA (CH) | 2025-05-01 | — | — | US | claimed |
| CN-119698458-A | Improvements in or relating to organic compounds improvements relating to organic compounds | 诺维信公司 | 2025-03-25 | — | — | CN | claimed |
| CN-113784759-B | Fragrance composition | 弗门尼舍有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118275560-A | Content determination and volatile oil fingerprint construction method for beta-asarone in grassleaf sweelflag rhizome | 天津中医药大学 | 2024-07-02 | — | — | CN | claimed |
| EP-4387583-A1 | ANTIMICROBIAL COMPOSITIONS | Firmenich SA (CH) | 2024-06-26 | — | — | EP | claimed |
| CN-118105365-A | Use of a compound in the manufacture of a medicament for preventing or treating idiopathic vomiting in a companion animal | 马斯公司 | 2024-05-31 | — | — | CN | claimed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | claimed |
| CN-118059089-A | Aromatic and anti-influenza prescription volatile oil preparation for preventing influenza and preparation method and application thereof | 中国中医科学院中医临床基础医学研究所 | 2024-05-24 | — | — | CN | claimed |
| EP-2836579-B1 | MALODOR REDUCTION COMPOSITIONS | PROCTER & GAMBLE (US) | 2018-07-25 | — | — | EP | claimed |
| CN-108143727-A | The new application of allyl benzene derivatives | 天津中医药大学 | 2018-06-12 | — | — | CN | claimed |
| WO-2018050721-A1 | FRAGRANCE COMPOSITIONS | GIVAUDAN SA (CH) | 2018-03-22 | — | — | WO | claimed |
| CN-107793231-A | A kind of Chinese cassia tree fertilizer and preparation method | 广西垚宇贸易有限公司 | 2018-03-13 | — | — | CN | claimed |
| EP-2986136-A1 | COMPOSITION AND METHOD FOR PREVENTING, REDUCING, ALLEVIATING, OR TREATING IDIOPATHIC VOMITING | The Iams Company (US) | 2016-02-24 | — | — | EP | claimed |
| CN-105188400-A | Compositions and methods for preventing, reducing, alleviating, or treating idiopathic vomiting | IAMS COMPANY | 2015-12-23 | — | — | CN | claimed |
| WO-2014143539-A1 | COMPOSITION AND METHOD FOR PREVENTING, REDUCING, ALLEVIATING, OR TREATING IDIOPATHIC VOMITING | THE IAMS COMPANY (US) | 2014-09-18 | — | — | WO | claimed |
| US-20140271949-A1 | Composition and Method for Preventing, Reducing, Alleviating or Treating Idiopathic Vomiting | THE IAMS COMPANY (US) | 2014-09-18 | — | — | US | claimed |
| EP-1993580-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | Moleac Pte Ltd. (SG) | 2008-11-26 | — | — | EP | claimed |
| WO-2007106049-A1 | COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION | MOLEAC PTE LTD (SG) | 2007-09-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | TYR 1284/4885MAPT 4309/4885SMN1; SMN2 3767/4885 |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | TYR 246/4885MAPT 2375/4885SMN1; SMN2 2793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.